Bixellou, sure thing, just want to make sure the o

Bixellou, sure thing, just want to make sure the other two patients also showed improvement which is very very important.

"Pourhassan, together diagnostics company IncellDx’s CEO Dr Bruce Patterson says evaluation of test results from the first four patients show “immunological benefits within three days” following treatment with leronlimab on all four patients, and “lower level of cytokine storm, especially IL-6 and TNF-α, which were reduced significantly.”